Dr. Viraj Master, MD, PhD
Claim this profileWinship Cancer Institute at Emory University
Studies Skin Cancer
Studies Prostate Cancer
3 reported clinical trials
9 drugs studied
Area of expertise
1Skin Cancer
Stage I
Stage II
2Prostate Cancer
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Viraj Master, MD, PhD is currently running
Survivorship Care Plan
for Prostate Cancer
This clinical trial compares the impact of a tailored survivorship care plan (SCP) to a standard SCP on the understanding of and access to survivorship care in black or African American patients with prostate cancer that has not spread to other parts of the body (localized) or that has spread from where it first started (primary site) to a limited number of places in the body (oligometastatic). SCPs summarize treatment history and recommendations for monitoring and maintaining health, and may also include potential long term effects of treatments received. The intention of a SCP is to help patients participate in their own health care. However, many patients have below basic levels of health literacy, meaning, they have a lower ability to obtain, communicate, process and understand basic health information and services to make health decisions. In fact, poor health literacy has been linked with worse quality of life in prostate cancer survivors. A tailored SCP includes the addition of an educational supplement based on lower reading and writing skills (low literacy) and may address health literacy barriers to understanding of treatment options and side effects. A standard SCP uses a template based on the American Society of Clinical Oncology (ASCO) guidelines for prostate cancer. A tailored SCP with low literacy educational supplements may be more effective compared to a standard SCP in improving understanding and access to survivorship care in black or African American patients with localized or oligometastatic prostate cancer.
Recruiting1 award N/A
Multiple Therapies
for Advanced Penile Cancer
This is an international phase III trial, with a Bayesian design, incorporating two sequential randomisations. It efficiently examines a series of questions that routinely arise in the sequencing of treatment. The study design has evolved from lengthy international consultation that has enabled us to build consensus over which questions arise from current knowledge and practice. It will enable potential randomisation for the majority of patients with inguinal lymph node metastases and will provide data to inform future clinical decisions. InPACT-neoadjuvant patients are stratified by disease burden as assessed by radiological criteria. Treatment options are then defined according to the disease burden strata. Treatment is allocated by randomisation. Patients may be allocated to one of three initial treatments: A. standard surgery (ILND); B. neoadjuvant chemotherapy followed by standard surgery (ILND); or C. neoadjuvant chemoradiotherapy followed by standard surgery (ILND). After ILND, patients are defined as being at low or high risk of recurrence based on histological interpretation of the ILND specimen. Patients at high risk of relapse are eligible for InPACT-pelvis, where they are randomised to either: P. prophylactic PLND Q. no prophylactic PLND
Recruiting4 awards Phase 35 criteria
More about Viraj Master, MD, PhD
Clinical Trial Related1 year of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Viraj Master, MD, PhD has experience with
- Tailored Survivorship Care Plan
- Blood Sparing Protocol
- Standard Blood Replacement
- Cisplatin
- Ifosfamide
- ILND - Inguinal Lymph Node Dissection
Breakdown of trials Viraj Master, MD, PhD has run
Skin Cancer
Prostate Cancer
Kidney Cancer
Renal Cell Carcinoma
Penile Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Viraj Master, MD, PhD specialize in?
Viraj Master, MD, PhD focuses on Skin Cancer and Prostate Cancer. In particular, much of their work with Skin Cancer has involved Stage I patients, or patients who are Stage II.
Is Viraj Master, MD, PhD currently recruiting for clinical trials?
Yes, Viraj Master, MD, PhD is currently recruiting for 2 clinical trials in Atlanta Georgia. If you're interested in participating, you should apply.
Are there any treatments that Viraj Master, MD, PhD has studied deeply?
Yes, Viraj Master, MD, PhD has studied treatments such as Tailored Survivorship Care Plan, Blood Sparing Protocol, Standard Blood Replacement.
What is the best way to schedule an appointment with Viraj Master, MD, PhD?
Apply for one of the trials that Viraj Master, MD, PhD is conducting.
What is the office address of Viraj Master, MD, PhD?
The office of Viraj Master, MD, PhD is located at: Winship Cancer Institute at Emory University, Atlanta, Georgia 30322 United States. This is the address for their practice at the Winship Cancer Institute at Emory University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.